Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation, and Hepatitis C virus research.
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality
EASL position paper on clinical follow-up after HCV cure
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
Genome‐wide Association Study and Meta‐analysis on Alcohol‐Associated Liver Cirrhosis Identifies Genetic Risk Factors
Personalized surveillance for hepatocellular carcinoma in cirrhosis – using machine learning adapted to HCV status
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Non‐virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of <scp>ANRS CO</scp>12 CirVir cohort
Caspase‐cleaved keratin‐18 fragments increase during alcohol withdrawal and predict liver‐related death in patients with alcoholic liver disease
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather*
PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters